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Abstract CMP-Kdo synthetases from Gram-negative bacteria 
activate Kdo for incorporation into lipo- and capsule-polysac- 
charities. Here we report the crystal structure of the capsule- 
specific synthetase from E. coli at 2.3 A resolution. The enzyme 
is a dimer of 2 x 245 amino acid residues assuming C2 symmetry. 
It contains a central predominantly parallel [~-sheet with 
surrounding helices. The chain fold is novel; it is remotely 
related to a double Rossmaun fold. A large pocket at the 
carboxyl terminal ends of the central ~-strands most likely 
accommodates the catalytic center. A putative phosphate binding 
site at the loop between the first ~strand and the following helix 
is indicated by a bound iridium hexachloride anion. 
Key words: Capsular polysaccharide; CMP-Kdo synthetase 
(Escherichia coli); X-ray analysis; Crystal structure; 
Saccharide activation 
which 44% are identical with L-CKS. The kinetic data of the 
two isozymes differ distinctly [16]. 
The rapid spread of antibiotic resistance among bacterial 
strains and the fact that Kdo is absent from mammalian cells 
[17] make K-CKS an attractive target molecule for drug de- 
sign as an anti-infective measure. Cloning of the kpsU gene 
from the K5 antigen gene cluster [16] permitted structural 
analysis of this enzyme. Here, we describe the overexpression, 
purification, crystallization and X-ray structure determination 
of K-CKS. To our knowledge this is the first actually pre- 
sented structure of a sugar-activating enzyme. A short note 
announcing an L-CKS crystal structure has been given earlier 
[18]. The AMP-transferring enzyme kanamycin ucleotidyl- 
transferase [19] and the sugar phosphate-transferring e zyme 
galactose-l-phosphate uridylyltransferase [20] use similar sub- 
strates, but they do not activate sugars and they differ struc- 
turally from K-CKS. 
1. Introduction 2. Materials and methods 
The saccharide 2-keto-3-deoxy-manno-octonic acid (Kdo) is 
a characteristic component of lipopolysaccharides of Gram- 
negative bacteria [1-3]. Important enzymes of Kdo metabo- 
lism are CMP-Kdo synthetase (CKS), determined by the kdsB 
gene [4-6], and Kdo transferase, determined by the kdtA gene 
[7,8]. CKS catalyzes the activation of Kdo according to: 
CTP + Kdo M-~g~+CMP-Kdo + PPi, whereas Kdo transferase 
participates in the synthesis of the lipid A moiety of lipo- 
polysaccharide. Kdo and sialic acid are unique in as far as 
they are activated by coupling to monophospho- rather than 
to the usual diphosphonucleosides [9]. 
More recently, it was found that pathogenic E. coli with 
group II capsules [1,10,11] exhibit an elevated CKS activity 
at capsule permissive temperatures above 20°C that is clearly 
correlated with capsule expression [12-14]. This activity in- 
crease is caused by a second CKS determined by one of the 
temperature gulated capsule genes, kpsU [15]. The capsule- 
specific second enzyme was termed K-CKS in order to distin- 
guish it from the isozyme L-CKS engaged in lipopolysaccha- 
ride synthesis. K-CKS has recently been isolated and charac- 
terized [13-16]. It contains 245 amino acid residues among 
*Corresponding author. Fax: (49) (761) 203-5987. 
E-mail: schulz@bio5.chemie.uni-freiburg.de 
Abbreviations: CMP, cytidine 5'-monophosphate; CKS, CMP-Kdo 
synthetase; DTT, dithiothreitol; K-CKS, capsule-specific CKS; Kdo, 
2-keto-3-deoxy-manno-octonic acid;PEG, polyethylene glycol; MIR, 
multiple isomorphous replacement; NCS, non-crystallographic sym- 
metry 
2.1. Materials 
The restriction endonucleases EcoRI and HindllI used in the sub- 
cloning of the DNA fragment were purchased from Boehringer- 
Mannheim and New England Biolabs, respectively. Pfu DNA poly- 
merase and its buffer used in PCR amplification were from Strata- 
gene. The PCR purification kit and the gel extraction kit were sup- 
plied by Qiagen. T4-Ligase was obtained from Boehringer-Mannheim 
and Benzonase from Merck. All other chemicals were of the highest 
available purity. 
2.2. Expression and purification 
The gene ncoding K-CKS from E. coli was PCR-amplified from 
plasmid pCR3 [16] using the following primers: 5'-CCGGAATT- 
CATGAGCAAAGCAGTTATTGTC-3' containing an EcoRl site 
(underlined) and 5'-GCTGCAAGCTTCTTGTGGAACAGGGC-3' 
with a HindlII site. Primer design was based on the DNA sequence 
[15]. Digestion with EcoRI and HindllI yielded a750 bp amplification 
product which was inserted into the expression vector pUAKyI [21]. 
The resulting plasmid pUCKS was transformed into E. coli HB101 
cells. 
Transformed cells were grown at 37°C in LB-medium supplemented 
with 0.1 g-1-1 ampicillin. Expression was induced with 1 mM isopro- 
pyl-I]-D-thiogalactopyranoside (IPTG) after the cell culture reached an 
optical density of 0.6 at 578 nm. After a further 5 h incubation at the 
same temperature, cells were harvested by centrifugation and soni- 
cated (model 7100, Measuring and Scientific Equipment) wice for 5 
min in 20 mM Tris-HC1 pH 8.0 containing 5 mM MgC12, 2 mM DTT, 
5 mg.1-1 phenylmethylsulfonylfluoride (PMSF) and 500 U.1-1 Benzo- 
nase. The cell debris was removed by centrifugation at 13 000 × g for 
10 min and then at 80000xg for 1 h. After precipitation with 1.8 M 
ammonium sulfate, the protein was resuspended in buffer A (20 mM 
Tris-HC1 pH 7.5, 20 mM MgCI2, 2 mM DTT), dialyzed against he 
same buffer, and applied to a Reactive Red affinity column (Sigma) 
equilibrated with buffer A. The protein was eluted from the column 
with a linear gradient of 0-300 mM NaC1 in buffer A. Fractions 
containing overexpressed protein were identified by enzymatic activity 
[22] and SDS-PAGE. They were pooled, concentrated, equilibrated 
against buffer-A and further purified using a Resource-Q column 
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Fig. 1. Stereoview of a representative portion of the final (2Fo-Fc) electron density map at 2.3 A resolution. The figure shows a region around 
strand 134 of the model including residues 45Glu-Val-Trp-Val-Ala. The density map is contoured at the 1.3 o level. 
(Pharmacia). The purified protein was concentrated to about 30 g'1-1 
and stored with 40% glycerol at -20°C. The typical yield was between 
40 and 50 mg of pure protein from 1 liter culture. 
2.3. Crystallization 
Crystals were grown by the hanging drop method at 20°C. The 
protein was concentrated in a Centricon-10 centrifugation chamber 
(Amicon), dialyzed for 12 h against 5 mM MgC12 and 2 mM DTT 
in water and adjusted to a concentration of 16 g.1-1. Drops contained 
equal amounts of this protein solution and a solution of 16% PEG- 
20000, 100 mM Tris-HC1 pH 9.4, 200 mM calcium acetate, 5 mM 
MgCI~ and 2 mM DTT. The reservoir contained only 24% PEG- 
20000. Crystals appeared generally within 2 days and grew to max- 
imum dimensions of 800 x 600 × 150 p.m a after one week. The crystals 
were stored in 16% PEG-8000, 100 mM Tris-HCl pH 9.4, 200 mM 
calcium acetate and 5 mM MgCI2. 
2.4. Data collection and phase determination 
All X-ray diffraction data were collected at room temperature with 
a multi-wire area detector (model X1000, Siemens) using Cu-K a 
radiation from a rotating anode (model RU200B, Rigaku). Images 
were processed with the program XDS [23]. The structure was solved 
by multiple isomorphous replacement (MIR). Heavy atom derivatives 
were produced by soaking crystals in doped storage solutions (Table 
1). The heavy atom positions were located by difference Patterson 
maps and confirmed by cross-difference Fourier maps. For refinement 
of heavy atom parameters and phase calculation with solvent flatten- 
ing we used the program PHASES (W. Furey, 1991; University of 
Pittsburgh, PA, USA). 
3. Results and discussion 
3.1. Crystal structure determination 
The Mr of one subunit of K-CKS is 27 028. Gel permeation 
chromatography showed that the enzyme is dimeric. K-CKS 
crystals belong to space group P21 with unit cell parameters 
a=46.1 A, b= 133.5 A, c=48.3 A and [3= 102.5 ° and diffract 
to 1.9 A resolution on a rotating anode. With one dimer per 
asymmetric unit, the crystals contain 54% solvent (I'M =2.6 
A3/Da). Native diffraction data have been collected to 2.3 ,~ 
resolution and initial ,phases were derived from 5 heavy atom 
derivatives up to 2.6 A resolution resulting in a figure of merit 
of 0.60 (Table 1). They were improved by solvent flattening. 
The resulting electron density map revealed some secondary 
structure elements. After skeletonization with the program 
BONES [24], the molecular envelope was identified and used 
to generate a mask with the program MAMA [25], which also 
yielded an initial non-crystallographic relation (NCS) between 
the two subunits of the enzyme. The NCS matrix was im- 
Table 1 
Data collection and phase determination by multiple isomorphous replacement 
Native Derivatives 
MMA a PtC14b Na3 IrC16 c KAuC14 d PbC12 e 
Resolution f [A] 2.3 2.6 3.2 3.8 2.8 
Completeness 
total [%] 95 97 94 94 80 
outermost shell [%] 65 82 72 72 71 
Rsyra g [%] 6.8 6.1 10.2 5.2 6.3 
Riso h [%] 21.4 13.2 10.6 12.4 
Sites .16/.00/.01/81 .34/. 16/.49/61 .35/. 16/.50/69 .82/.35/.08/63 
xlylz/rel, occupancy .89/.07/.42/76 .09/.35/.24/59 








a Methylmercury acetate, 1 mM in storage buffer soaked for 3 days, the sites are at Cys-126 and Cys-126'. 
b Soaked, 2 mM in storage buffer for 1 day, the site is near Arg-10 and Lys-19. 
c Soaked, 1 mM in storage buffer for 1 day, the sites are near Arg-10, Lys-19 and Arg-10', Lys-19'. 
d Soaked, 5 mM in storage buffer for 2 days, the site is at Cys-229'. 
e Soaked, 1 mM in storage buffer for 1 day, the site is at Cys-229'. 
f Each data set was measured from a single crystal. 
g Rsym : ~h~i  J I (h ) i -  < I(h) > ]/~h~i I (h) i .  
h Riso = 2" E [ Fder -- Fnat I [ ~(Fder + Fnat)- 
i Values are for the total resolution range of the respective derivative, 
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Fig. 2. Stereoview of the Ca backbone of dimeric apsule-specific CMP-Kdo synthetase from E. coli (K-CKS). Some residue numbers are given. 
The molecular twofold axis is a dotted line. 
proved with the program IMP [25]. Subsequent density aver- 
aging with the program DM [26] yielded a map that revealed 
an unambiguous polypeptide chain trace. 
3.2. Model building and refinement 
The chain tracing was converted to a model using the pro- 
gram O [27] together with the DNA-derived amino acid se- 
quence of Pazzani et al. [15]. One subunit was fitted, and the 
other one was generated by NCS. The crystallographic R-fac- 
tor for this initial model was 38.5%. The model was then 
refined using the program X-PLOR [28] with NCS restraints 
for all residues that are not involved in interface or packing 
contacts. No solvent molecules were included at this stage. 
The refinement converged at an R-factor of 22.5% for all 
data in the resolution range 10-2.3 ,~. The free R-factor as 
based on a 5% test set of about 1100 reflections was 26.6%. 
The current model consists of 2 × 241 amino acid residues, 
the 4 C-terminal residues are mobile and invisible. A repre- 
sentative portion of the electron density map is shown in Fig. 
1. The quality of the model is satisfying because all non-gly- 
cine residues have main-chain dihedral angles in 'allowed' 
regions with 93% of them in 'most favored' regions [29]. 
The root mean square deviations from standard are below 
0.01 ,~ and 1.4 ° for bond lengths and angles, respectively. A 
cis-peptide precedes Pro-159 in both subunits. The NCS re- 
lates the two subunits by an exact 180 ° rotation without trans- 
lation. 
3.3. Structure and catalysis 
The chain fold of dimeric K-CKS is shown in Fig. 2. One 
subunit is a single a/13 domain of approximate dimensions 
55 5< 45 × 40 ,~3. About 60% of the amino acids are in second- 
ary structural elements, i.e. in nine a-helices, two short 310- 
helices and 11 I]-strands. A topology graph is given in Fig. 3. 
139 ] 
179 ( 
Fig. 3. Topology diagram of one subunit of the capsule-specific 
CMP-Kdo synthetase from E. coli (K-CKS). The [3-strands are re- 
presented by single squares if they point towards the viewer and as 
double squares if they point in the opposite direction; I~-strands ly- 
ing approximately in the plane of the paper are drawn as arrows. 
The ct-helices are circles and the 310-helices are hexagons. The posi- 
tional numbers denote residues preceding a secondary structure le- 
ment. 
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Fig. 4. Ribbon plot of one subunit of the dimeric capsule-specific 
CMP-Kdo synthetase produced with MOLSCRIPT [36]. Helices are 
given as coils and 13-strands a arrows. The molecular twofold axis 
is a broken line. Arg-10 and Lys-19 are depicted together with the 
IrC16 3- anion at a putative phosphate binding site. 
The dominant feature is a seven-stranded predominantly par- 
allel [3-sheet flanked on both sides by a-helices. The ~-sheet 
shows the usual twist. Strand 1310, which contains a bulge at 
residue Gly-174, is antiparallel to the other six strands. It 
forms additional hydrogen bonds with strand [38. Strands [36 
and 137 are joined by helix a4 forming an unusual eft-handed 
[3a[3 connection. At one end, the major [3-sheet is extended to 
a further smaller [3-sheet that participates in a 40 residue chain 
excursion connecting strands [37 and 1310. This excursion 
forms most of the subunit interface (Fig. 2). The chain ends 
in helix a9 far away from the interface. 
If the antiparallel strand [310 of the central sheet were ig- 
nored (taking residues 125-211 as the connection between [37 
and [311) and if [36 and 137 were connected in a right-handed 
manner, the chain topology would resemble the double Ross- 
mann fold of the lactate dehydrogenase family [30]. The to- 
pology (Fig. 3) indicates that during early evolution these two 
changes could have occurred concomitantly in a continuous 
manner, rendering the CKS-fold a derivative of the more 
abundant double Rossmann fold. 
While the monomer is reasonably compact, the dimer is 
very extended (Fig. 2) with approximate dimensions of 
90 ×45 X40 .~3. It is formed through tight interactions, in- 
volving mostly helix c~7 and the long loop between strand 
139 and the following 310-helix. These form nonpolar contacts 
together with a total of 18 hydrogen bonds between the two 
subunits, most of which are between side chain atoms. As 
judged from Fig. 2, the subunit can be subdivided into two 
wings that line a large pocket in between. The first wing con- 
sists of residues 1-100 together with the C-terminal ct-helix, 
while the second wing contains the remaining residues and 
forms the dimer interface. 
The pocket is at the carboxy terminal ends of the central 
predominantly parallel 13-sheet, where numerous other en- 
zymes of such a construction have their catalytic centers. 
The pocket is large enough to accommodate the substrates 
CTP and Kdo. Furthermore, several amino acid residues 
within this pocket are conserved between K-CKS and other 
CMP-Kdo synthetases. Drawing from other mononucleotide 
binding enzymes with a central parallel [3-sheet like the ade- 
nylate kinases [31] one would expect that the loop between 
strand 131 and the following 310-helix binds a phosphate of 
CTP. This suggestion is supported by the observation that 
the heavy atom anion IrC16 a- binds at Arg-10 and Lys-19 
close to this loop as sketched in Fig. 4 and noted in Table 
1. The amino acid sequence after strand 131 is lZGly-Ser-Ser- 
Arg-Leu-Pro-Gly-Lys, which resembles the mononucleotide 
sequence fingerprint Gly-x-x-Gly-x-Gly-Lys only vaguely. It 
should be kept in mind, however, that CKS transfers a double 
phosphoryl group to water forming a pyrophosphate and not 
a single phosphoryl group like the kinases and the G-proteins 
[31]. 
A search through the Protein Data Bank using the program 
DALI [32] indicated that the chain fold of K-CKS is not 
related to any deposited protein. The sequence of K-CKS is 
40-44% identical with CMP-Kdo synthetases involved in lipo- 
polysaccharide synthesis (L-CKS) in various Gram-negative 
bacteria [6,33,34] and shows 21% identity to the CMP-N-acet- 
ylneuraminic acid synthetase encoded by the K1 antigen re- 
gion-2 of E. coli [35]. All these enzymes catalyze the genera- 
tion of CTP-activated sugar nucleotides. The presence of 
K-CKS in addition to L-CKS (lipopolysaccharide biogenesis) 
presumably allows for an independent regulation of group II 
capsule expression [15]. These capsules constitute important 
virulence determinants of pathogenic E. coli strains causing 
extraintestinal infections. 
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